Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass ...

Nearing its 14th anniversary, Notre Dame’s Wilson Sheehan Lab for Economic Opportunity continues evaluating the impact of ...

Maintaining a healthy blood sugar level can reduce your disease risk and give you more energy. These 15 habits help keep ...

For people with eczema, symptoms do not differ with weekly versus daily bathing, according to a study published online Nov. 9 ...

A phase 2 RCT evaluated progression of prostate-specific antigen and urinary symptoms in men with low-risk prostate cancer who were administered phytochemical-rich food and Lactobacillus probiotic ...

Upending previous research, study finds no evidence of status-quo bias favoring standard care when two or more appropriate alternatives are presented.

Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy ...

The FDA has accepted the new drug application (NDA) of the synthetic, targeted radiotherapeutic agent 177 Lu-edotreotide (ITM ...

Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 ...

An apple a day keeps the doctor away, or so the old proverb says. But, is there any truth to it? Apples are both affordable ...